A Double‐Blind, Randomized, Placebo‐Controlled Trial of Macrolide in the Treatment of Chronic Rhinosinusitis
Top Cited Papers
- 1 February 2006
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 116 (2) , 189-193
Abstract
Objectives: The antiinflammatory effect of macrolide antibiotics has been well‐established, as has their role in the treatment of certain disorders of chronic airway inflammation. Several studies have suggested that long‐term, low‐dose macrolides may be efficacious in the treatment of chronic rhinosinusitis; however, these studies have lacked a control group. To date, this effect has not been tested in a randomized, placebo‐controlled study.Method: The authors conducted a double‐blind, randomized, placebo‐controlled clinical trial on 64 patients with chronic rhinosinusitis. Subjects received either 150 mg roxithromycin daily for 3 months or placebo. Outcome measures included the Sinonasal Outcome Test‐20 (SNOT‐20), measurements of peak nasal inspiratory flow, saccharine transit time, olfactory function, nasal endoscopic scoring, and nasal lavage assays for interleukin‐8, fucose, and a2‐macroglobulin.Results: There were statistically significant improvements in SNOT‐20 score, nasal endoscopy, saccharine transit time, and IL‐8 levels in lavage fluid (P < .05) in the macrolide group. A correlation was noted between improved outcome measures and low IgE levels. No significant improvements were noted for olfactory function, peak nasal inspiratory flow, or lavage levels for fucose and a2‐macroglobulin. No improvement in any outcome was noted in the placebo‐treated patients.Conclusion: These findings suggest that macrolides may have a beneficial role in the treatment of chronic rhinosinusitis, particularly in patients with low levels of IgE, and supports the in vitro evidence of their antiinflammatory activity. Additional studies are required to assess their place in clinical practice.Keywords
This publication has 14 references indexed in Scilit:
- Challenge‐induced plasma exudation and mucinous secretion in human airwaysClinical Physiology and Functional Imaging, 2005
- Australian norms for a quantitative olfactory function testJournal of Clinical Neuroscience, 2004
- Evaluation of the Medical and Surgical Treatment Of Chronic Rhinosinusitis: A Prospective, Randomised, Controlled TrialThe Laryngoscope, 2004
- Clarithromycin and Prednisolone Inhibit Cytokine Production in Chronic RhinosinusitisThe Laryngoscope, 2002
- One‐Year Low‐Dose Erythromycin Treatment of Persistent Chronic Sinusitis after Sinus Surgery: Clinical Outcome and Effects on Mucociliary Parameters and Nasal Nitric OxideOtolaryngology–Head and Neck Surgery, 2002
- Mode of Action of Long-Term Low-Dose Macrolide Therapy for Chronic Sinusitis in the Light of Neutrophil RecruitmentCurrent Drug Targets - Inflammation & Allergy, 2002
- Prognostic Factors of Chronic Rhinosinusitis under Long-Term Low-Dose Macrolide TherapyORL, 2000
- Effects of Clarithromycin on Cultured Human Nasal Epithelial Cells and FibroblastsThe Laryngoscope, 2000
- Outcomes assessmentOtolaryngology–Head and Neck Surgery, 1997
- Adult rhinosinusitis definedOtolaryngology–Head and Neck Surgery, 1997